Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis, inadequate treatment, and stigmatization. AI can enhance migraine management through improved diagnosis, prediction, and personalized education. The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients' understanding of their condition more effectively.

Who May Be Eligible (Plain English)

Who May Qualify: - aged between 18 and 65 years at the time of signing the willing to sign a consent form - Newly diagnosis of migraine, confirmed through the medical chart - The participant must be capable of giving signed willing to sign a consent form - Access to a laptop, computer, smartphone, or tablet Who Should NOT Join This Trial: - Insufficient knowledge of the protocol language (italian) - Patients with cognitive impairment and/or unable to use or access the AI-powered learning platform developed in this study. - Vulnerable participants (e.g. minors, participants incapable of judgment or participants under tutelage) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * aged between 18 and 65 years at the time of signing the informed consent * Newly diagnosis of migraine, confirmed through the medical chart * The participant must be capable of giving signed informed consent * Access to a laptop, computer, smartphone, or tablet Exclusion Criteria: * Insufficient knowledge of the protocol language (italian) * Patients with cognitive impairment and/or unable to use or access the AI-powered learning platform developed in this study. * Vulnerable participants (e.g. minors, participants incapable of judgment or participants under tutelage)

Treatments Being Tested

OTHER

AI-assisted migraine education (AIME)

AIME Group will undergo the established migraine education plus AI-assisted education.

Locations (1)

Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano
Lugano, Switzerland